Merck and Co. (Whitehouse Station, NJ) has entered into an agreement with the biotechnology company C Sixty (Houston, TX) for the development and commercialization of C Sixty's fullerene antioxidant technology.
The European Union has introduced new legislation designed to encourage pharmaceutical companies to develop treatments for "orphan" (rare) diseases that affect fewer than five people in every 10000 within the 15 member bloc.
An increasing number of drug candidates synthesized each year by pharmaceutical companies are considered poorly water-soluble. Most of these compounds are dropped from development because they can't be formulated properly.
ON OCT. 3, the United States Department of Justice announced what is to date the largest health care fraud settlement in history. In addition to paying the unprecedented sum of $875 million, Lake Forest, Ill.-based TAP Pharmaceutical Products agreed to plead guilty to felony conspiracy to violate the Prescription Drug Marketing Act.
KANSAS CITY, Mo. -- Criminal allegations were raised against a Kansas City pharmacist last month for diluting patients' chemotherapy drugs. The pharmacists met swift condemnation from industry leaders who characterized the incident as "an uncommon occurrence."